Zobrazeno 1 - 8
of 8
pro vyhledávání: '"David A Barvir"'
Autor:
Simon Pollett, Caitlin H Kuklis, David A Barvir, Richard G Jarman, Rachel M Romaine, Brett M Forshey, Gregory D Gromowski
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 1, p e0009986 (2022)
Understanding the burden and risk factors of dengue virus (DENV) infection in Puerto Rico is important for the prevention of dengue in local, traveler and military populations. Using sera from the Department of Defense Serum Repository, we estimated
Externí odkaz:
https://doaj.org/article/34814df50fd445dfada263aa00a3e1ad
Autor:
Kristin Hatch, Mark A. Sanborn, Gregory D. Gromowski, Hayden Siegfried, Michael K. McCracken, Shannon D Walls, Caitlin Kuklis, Heather Friberg, Wiriya Rutvisuttinunt, Richard G. Jarman, Rafael De La Barrera, Chandrika B. Kannadka, David A. Barvir, Kaitlin Victor, Jeffrey R. Currier, Adam T. Waickman
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-12 (2021)
NPJ Vaccines
NPJ Vaccines
Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost strategy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7532cf56b2bf4755c7dfd48de6bc36b5
https://doi.org/10.1038/s41541-021-00339-y
https://doi.org/10.1038/s41541-021-00339-y
Autor:
Stephen J. Thomas, Richard G. Jarman, Sandra Henein, Chandrika B. Kannadka, Aravinda M. de Silva, Gregory D. Gromowski, David A. Barvir
Publikováno v:
Vaccine. 36:2403-2410
The dengue virus (DENV) vaccines that are licensed or in clinical development consist of DENV serotype 1-4 tetravalent formulations given simultaneously and are not acquired sequentially like natural infections. It is unclear what effect this has on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386ecb32148d66e0ec7cc11a38bb9cc0
https://doi.org/10.1016/j.vaccine.2018.03.055
https://doi.org/10.1016/j.vaccine.2018.03.055
Autor:
Russell A. Olson, Bruce L. Innis, J. Robert Putnak, Wangdon Yoo, David W. Vaughn, Sun P. Hong, Soo-Ok Kim, Sang B. Moon, David A. Barvir, Ashok K. Srivastava, Kenneth H. Eckels, Bangti Zhao, Andrew C. Towle, Sung H. Lee
Publikováno v:
Vaccine. 19:4557-4565
A second generation, purified, inactivated vaccine (PIV) against Japanese encephalitis (JE) virus was produced and tested in mice where it was found to be highly immunogenic and protective. The JE-PIV was made from an attenuated strain of JE virus pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3f45fb50cc1606491d98e63ae467f9
https://doi.org/10.1016/s0264-410x(01)00208-0
https://doi.org/10.1016/s0264-410x(01)00208-0
Autor:
Richard G. Jarman, Peifang Sun, Stephen B. Thomas, Robert V. Gibbons, Julia Lynch, Robert Putnak, Timothy Burgess, Edwin Kamau, Dupeh R. Palmer, Ratree Takhampunya, Sasha McClain, David A. Barvir, Chunlin Zhang
Publikováno v:
Virus research. 145(1)
Eighteen dengue viruses (DENVs) representing all four serotypes, isolated from pediatric patients at children's hospital, Queen Sirikit National Institute of Child Health, Bangkok, Thailand exhibiting a diverse spectrum of disease ranging from uncomp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80089d431091eab62c9f50454194be9c
https://pubmed.ncbi.nlm.nih.gov/19540887
https://pubmed.ncbi.nlm.nih.gov/19540887
Autor:
Charles H. Hoke, Robert Putnak, Jeanne Burrous, Jerald C. Sadoff, David A. Barvir, Valerie M. D'Andrea, Doria R. Dubois, Kenneth H. Eckels
Publikováno v:
The Journal of infectious diseases. 174(6)
The feasibility of a purified, inactivated dengue (DEN) vaccine made in Vero cells was explored. A DEN-2 virus candidate was chosen for production of a monotypic, purified, inactivated vaccine (PIV). Virus was harvested from roller bottle culture sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c185e30fd0887f345271f39ddf0189
https://pubmed.ncbi.nlm.nih.gov/8940206
https://pubmed.ncbi.nlm.nih.gov/8940206
Autor:
David A. Barvir, Doria R. Dubois, C.T. Rankin, John R. Ticehurst, S.P. O'Neill, Kenneth H. Eckels, R.L. Timchak, Leonard N. Binn
Publikováno v:
Journal of virological methods. 32(2-3)
Formalin-inactivated hepatitis A virus (HAV) can be purified for vaccine preparation by centrifugation in Renografin-76 (diatrizoate meglumine and diatrizoate sodium) gradients. Both continuous-flow rate-zonal and isopycnic methods were used for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75140f7209c0235b02df57207a4f4ceb
https://pubmed.ncbi.nlm.nih.gov/1651954
https://pubmed.ncbi.nlm.nih.gov/1651954
Autor:
Michael K. McCracken, Caitlin H. Kuklis, Chandrika B. Kannadka, David A. Barvir, Mark A. Sanborn, Adam T. Waickman, Hayden C. Siegfried, Kaitlin A. Victor, Kristin L. Hatch, Rafael De La Barrera, Shannon D. Walls, Wiriya Rutvisuttinunt, Jeffrey R. Currier, Heather Friberg, Richard G. Jarman, Gregory D. Gromowski
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-12 (2021)
Abstract Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost str
Externí odkaz:
https://doaj.org/article/d8ee938ae9d948e0b132ccac35634eaa